Latest Insider Transactions at Mimedx Group, Inc. (MDXG)
This section provides a real-time view of insider transactions for Mimedx Group, Inc. (MDXG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MIMEDX GROUP, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MIMEDX GROUP, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 13
2023
|
William Frank Iv Hulse General Counsel and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
136,364
+22.33%
|
$545,456
$4.62 P/Share
|
|
Mar 13
2023
|
William Lawrence Phelan Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,030
+21.44%
|
$212,120
$4.62 P/Share
|
|
Mar 07
2023
|
William Frank Iv Hulse General Counsel and CAO |
SELL
Open market or private sale
|
Direct |
11,308
-3.24%
|
$45,232
$4.24 P/Share
|
|
Mar 07
2023
|
Peter M Carlson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,056
-2.21%
|
$48,224
$4.24 P/Share
|
|
Mar 07
2023
|
William Lawrence Phelan Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,396
-2.35%
|
$13,584
$4.24 P/Share
|
|
Mar 07
2023
|
Robert Benjamin Stein President, Regenerative Med. |
SELL
Open market or private sale
|
Direct |
12,355
-4.43%
|
$49,420
$4.24 P/Share
|
|
Feb 23
2023
|
William Frank Iv Hulse General Counsel and CAO |
SELL
Open market or private sale
|
Direct |
15,555
-4.26%
|
$62,220
$4.53 P/Share
|
|
Feb 23
2023
|
Peter M Carlson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
19,000
-3.36%
|
$76,000
$4.5 P/Share
|
|
Feb 13
2023
|
Ricci S Whitlow Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
462,857
+50.0%
|
$1,388,571
$3.5 P/Share
|
|
Dec 22
2022
|
Peter M Carlson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,992
-0.88%
|
$9,984
$2.82 P/Share
|
|
Sep 15
2022
|
Todd Newton Director |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+38.05%
|
-
|
|
Sep 13
2022
|
Robert Benjamin Stein President, Regenerative Med. |
SELL
Open market or private sale
|
Direct |
8,329
-2.9%
|
$24,987
$3.46 P/Share
|
|
Sep 12
2022
|
Robert Benjamin Stein President, Regenerative Med. |
SELL
Open market or private sale
|
Direct |
19,000
-6.21%
|
$57,000
$3.44 P/Share
|
|
Aug 12
2022
|
Robert Benjamin Stein President, Regenerative Med. |
SELL
Open market or private sale
|
Direct |
8,503
-2.7%
|
$34,012
$4.04 P/Share
|
|
Aug 09
2022
|
Rohit Kashyap President, WC & Surgical |
SELL
Open market or private sale
|
Direct |
12,343
-2.79%
|
$49,372
$4.21 P/Share
|
|
Aug 04
2022
|
Robert Benjamin Stein President, Regenerative Med. |
SELL
Open market or private sale
|
Direct |
19,500
-5.84%
|
$58,500
$3.62 P/Share
|
|
Jun 28
2022
|
Robert Benjamin Stein President, Regenerative Med. |
SELL
Open market or private sale
|
Direct |
14,600
-4.19%
|
$43,800
$3.47 P/Share
|
|
Jun 10
2022
|
Michael J Giuliani Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,191
+31.8%
|
$132,573
$3.96 P/Share
|
|
Jun 09
2022
|
Timothy R Wright Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
112,000
-6.14%
|
$336,000
$3.75 P/Share
|
|
Jun 07
2022
|
M Kathleen Behrens Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,191
+26.02%
|
$132,573
$3.96 P/Share
|
|
Jun 07
2022
|
James L Bierman Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,191
+26.02%
|
$132,573
$3.96 P/Share
|
|
Jun 07
2022
|
Phyllis Gardner Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,191
+35.11%
|
$132,573
$3.96 P/Share
|
|
Jun 07
2022
|
William A Hawkins Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,191
+27.44%
|
$132,573
$3.96 P/Share
|
|
Jun 07
2022
|
Cato T Laurencin Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,191
+31.8%
|
$132,573
$3.96 P/Share
|
|
Jun 07
2022
|
Todd Newton Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,191
+26.02%
|
$132,573
$3.96 P/Share
|
|
May 09
2022
|
Mark Graves SVP & Chief Compliance Officer |
SELL
Open market or private sale
|
Direct |
3,891
-2.83%
|
$11,673
$3.5 P/Share
|
|
May 06
2022
|
William Lawrence Phelan Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,750
-3.82%
|
$17,250
$3.81 P/Share
|
|
May 02
2022
|
Scott M Turner SVP, Operations & Procurement |
SELL
Open market or private sale
|
Direct |
5,260
-2.27%
|
$21,040
$4.0 P/Share
|
|
Apr 08
2022
|
Robert Benjamin Stein President, Regenerative Med. |
BUY
Grant, award, or other acquisition
|
Direct |
178,571
+33.87%
|
$714,284
$4.62 P/Share
|
|
Apr 08
2022
|
Peter M Carlson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
187,500
+24.75%
|
$750,000
$4.62 P/Share
|
|
Apr 08
2022
|
Rohit Kashyap President, WC & Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
178,571
+28.76%
|
$714,284
$4.62 P/Share
|
|
Apr 08
2022
|
William Lawrence Phelan Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,030
+26.07%
|
$212,120
$4.62 P/Share
|
|
Apr 08
2022
|
Scott M Turner SVP, Operations & Procurement |
BUY
Grant, award, or other acquisition
|
Direct |
61,472
+20.95%
|
$245,888
$4.62 P/Share
|
|
Apr 08
2022
|
Mark Graves SVP & Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,485
+26.07%
|
$193,940
$4.62 P/Share
|
|
Apr 08
2022
|
William Frank Iv Hulse General Counsel and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
178,571
+32.86%
|
$714,284
$4.62 P/Share
|
|
Apr 08
2022
|
Timothy R Wright Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
602,679
+24.84%
|
$2,410,716
$4.62 P/Share
|
|
Mar 08
2022
|
William Lawrence Phelan Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,268
-3.25%
|
$13,072
$4.86 P/Share
|
|
Mar 08
2022
|
Robert Benjamin Stein President, Regenerative Med. |
SELL
Open market or private sale
|
Direct |
11,672
-6.42%
|
$46,688
$4.86 P/Share
|
|
Mar 08
2022
|
William Frank Iv Hulse General Counsel and CAO |
SELL
Open market or private sale
|
Direct |
9,990
-5.09%
|
$39,960
$4.86 P/Share
|
|
Mar 08
2022
|
Peter M Carlson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,743
-2.73%
|
$42,972
$4.86 P/Share
|
|
Mar 08
2022
|
Mark Graves SVP & Chief Compliance Officer |
SELL
Open market or private sale
|
Direct |
3,234
-3.51%
|
$12,936
$4.86 P/Share
|
|
Mar 08
2022
|
Rohit Kashyap President, WC & Surgical |
SELL
Open market or private sale
|
Direct |
8,770
-3.22%
|
$35,080
$4.86 P/Share
|
|
Mar 08
2022
|
Scott M Turner SVP, Operations & Procurement |
SELL
Open market or private sale
|
Direct |
4,155
-2.38%
|
$16,620
$4.86 P/Share
|
|
Mar 08
2022
|
Timothy R Wright Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
45,611
-3.6%
|
$182,444
$4.86 P/Share
|
|
Feb 25
2022
|
Peter M Carlson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,400
-4.24%
|
$69,600
$4.83 P/Share
|
|
Feb 24
2022
|
Mark Graves SVP & Chief Compliance Officer |
SELL
Open market or private sale
|
Direct |
4,525
-4.68%
|
$18,100
$4.32 P/Share
|
|
Feb 23
2022
|
William Frank Iv Hulse General Counsel and CAO |
SELL
Open market or private sale
|
Direct |
13,500
-6.43%
|
$54,000
$4.41 P/Share
|
|
Feb 23
2022
|
Scott M Turner SVP, Operations & Procurement |
SELL
Open market or private sale
|
Direct |
5,738
-3.18%
|
$22,952
$4.5 P/Share
|
|
Feb 23
2022
|
Timothy R Wright Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
61,000
-4.6%
|
$244,000
$4.31 P/Share
|
|
Aug 16
2021
|
Robert Benjamin Stein President, Regenerative Med. |
SELL
Open market or private sale
|
Direct |
9,362
-4.9%
|
$102,982
$11.85 P/Share
|